Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Admission clinical parameters in predicting in-hospital mortality in COVID-19 Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021
Predictors of in-hospital mortality following in-hospital diagnosis of tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 128s Year: 2006
Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
CURB-65 scoring utilization in predicting mortality of hospitalized patients with AE-COPD Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012
eCURB outperforms CURB-65 and A-DROP for predicting 30-day mortality in pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Predictors of 30-day mortality in elderly patients with community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013
A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006
Mortality predictions of CURB-65, GPS and CALL scores in hospitalized patients with COVID-19 Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021
On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008
Severity assessment tools for predicting 30-day mortality in community acquired pneumonia – systematic review and meta-analysis Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009
Predicting in-hospital death in pneumonic COPD exacerbation via BAP-65, CURB-65 and machine learning Source: ERJ Open Res, 8 (1) 00452-2021; 10.1183/23120541.00452-2021 Year: 2022
Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk Source: Virtual Congress 2021 – COVID - 19 Year: 2021
Birmingham Community Acquired Pneumonia Severity score (BCAPS) is a better predictor of mortality than CURB65 in hospitalised patients with community acquired pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020
Treatment changes, readmission rates and mortality in a COPD hospital at home scheme Source: Eur Respir J 2005; 26: Suppl. 49, 286s Year: 2005
Scoring system predicting mortality in melioidosis Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012